Bongers M

No ORCID on file · 9 papers in corpus · active 2015-2023

Study types

  • article 2
  • review 2
  • other 1

Condition tags

  • endometriosis 5
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • irritable_bowel_syndrome 1
  • endometrioma 1
  • dyspareunia 1
other 2023
Frontiers in nutrition ·doi:10.3389/fnut.2023.1295983

[This corrects the article DOI: 10.3389/fnut.2023.1166929.].

review 2023
Frontiers in nutrition ·doi:10.3389/fnut.2023.1166929

Endometriosis is characterized by the presence of endometrium-like tissue outside the uterus. The etiology remains largely unknown. Despite adequate treatment, patients can still experience symptoms or side effects resulting in therapy inco…

review 2023
·doi:10.22541/au.169699534.44265287/v1

Background- For patients with endometrioma it is unclear what treatment: surgery and/or medication, is more effective in reducing pain and improving quality of life (QoL). Objectives- To provide an overview of existing evidence on effects o…

2022
The Cochrane database of systematic reviews
article 2021
Life (Basel, Switzerland) ·doi:10.3390/life12010015

Introduction: Endometriosis surgery is associated with a high risk of reoperation due to an insufficient recognition of endometriotic lesions. Our aim was to explore the role of near-infrared fluorescence (NIRF) imaging for the visualizatio…

article 2019
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2019.10.011

Research questionTo evaluate the findings of outpatient transvaginal hydrolaparoscopy (THL) in comparison with diagnostic laparoscopy combined with chromopertubation in subfertile women.DesignIn a retrospective study in four large teaching …

2018
Frontiers in pharmacology ·doi:10.3389/fphar.2018.00940

Our understanding of the intracrine (or local) regulation of estrogen and other steroid synthesis and degradation expanded in the last decades, also thanks to recent technological advances in chromatography mass-spectrometry. Estrogen respo…

2016
Gynecological Surgery ·doi:10.1007/s10397-015-0915-3

The FAST-EU Trial was designed to establish the effectiveness and confirm the safety of transcervical intrauterine sonography-guided radiofrequency ablation with the VizAblate™ System in the treatment of symptomatic uterine fibroids. This w…

2015
Gynecological Surgery ·doi:10.1007/s10397-014-0873-1

This was a prospective, longitudinal, multicenter, single-arm controlled trial, using independent core laboratory validation of MRI results, to establish the effectiveness and confirm the safety of the VizAblate® System in the treatment of …